GORACCI, ARIANNA
 Distribuzione geografica
Continente #
EU - Europa 10.505
NA - Nord America 8.359
AS - Asia 3.522
SA - Sud America 579
AF - Africa 234
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.233
Nazione #
US - Stati Uniti d'America 8.229
RU - Federazione Russa 3.251
IT - Italia 2.244
GB - Regno Unito 1.784
CN - Cina 1.224
SG - Singapore 1.172
IE - Irlanda 855
SE - Svezia 482
BR - Brasile 477
UA - Ucraina 447
FR - Francia 352
DE - Germania 308
HK - Hong Kong 275
VN - Vietnam 273
PL - Polonia 210
FI - Finlandia 184
ZA - Sudafrica 123
ES - Italia 121
KR - Corea 121
IN - India 114
NL - Olanda 95
CA - Canada 77
JP - Giappone 72
BD - Bangladesh 47
IQ - Iraq 40
MX - Messico 39
TR - Turchia 39
AR - Argentina 38
NG - Nigeria 29
AU - Australia 27
CH - Svizzera 26
PK - Pakistan 22
AT - Austria 20
BE - Belgio 19
GR - Grecia 17
IR - Iran 16
MY - Malesia 15
CI - Costa d'Avorio 14
EC - Ecuador 14
CZ - Repubblica Ceca 12
EG - Egitto 12
MA - Marocco 12
PT - Portogallo 11
SA - Arabia Saudita 11
VE - Venezuela 11
KE - Kenya 10
RO - Romania 10
UY - Uruguay 10
CL - Cile 9
JO - Giordania 9
BG - Bulgaria 8
DK - Danimarca 8
PH - Filippine 8
TW - Taiwan 8
UZ - Uzbekistan 8
HU - Ungheria 7
ID - Indonesia 7
CO - Colombia 6
PE - Perù 6
TN - Tunisia 6
AZ - Azerbaigian 5
DZ - Algeria 5
KZ - Kazakistan 5
PY - Paraguay 5
UG - Uganda 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LU - Lussemburgo 4
NO - Norvegia 4
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
JM - Giamaica 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
SI - Slovenia 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
Totale 23.210
Città #
Southend 1.609
Dublin 844
Dallas 784
Ashburn 775
Fairfield 748
Singapore 613
Houston 585
Chandler 470
Santa Clara 397
Moscow 385
Woodbridge 372
Jacksonville 352
Beijing 330
San Jose 311
Milan 307
Seattle 286
Wilmington 275
Hong Kong 261
Cambridge 245
Ann Arbor 208
Hefei 167
Siena 167
Rome 165
Princeton 150
The Dalles 145
Council Bluffs 120
Seoul 115
Johannesburg 111
Los Angeles 110
Nanjing 108
Helsinki 99
Málaga 89
Lauterbourg 86
Florence 82
Ho Chi Minh City 71
San Mateo 70
Warsaw 69
New York 67
Boardman 65
Washington 58
Hanoi 57
Dong Ket 52
Munich 49
Orem 46
Nanchang 43
San Diego 43
Buffalo 39
São Paulo 39
Tianjin 38
Naples 36
Menlo Park 35
Turin 32
Chennai 31
Columbus 31
London 30
Shenyang 30
Bologna 29
Abuja 28
Norwalk 28
Brooklyn 27
Hebei 23
Palermo 23
Redondo Beach 23
Dearborn 22
Jiaxing 22
Tokyo 22
Chicago 20
Montreal 20
Prato 20
San Francisco 20
Toronto 19
Belo Horizonte 18
Brussels 18
Figino 18
Frankfurt am Main 18
Stockholm 18
Bengaluru 17
Kunming 17
Catania 16
Changsha 16
Jinan 16
Rio de Janeiro 16
Trento 16
Turku 16
Verona 16
Brescia 15
Fremont 15
Nuremberg 15
Redwood City 15
Shanghai 15
Abidjan 14
Da Nang 14
Guangzhou 14
Krakow 14
Mumbai 14
Cagliari 13
Curitiba 13
Zhengzhou 13
Amsterdam 12
Genoa 12
Totale 13.692
Nome #
Questionnaire for the Assessment of Quality of Life in Healthy Subjects (VQV-ss): Elaboration of a new instrument for the assessment of quality of life in the general population [Questionario per la Valutazione della Qualità della Vita nei soggetti sani (VQV-ss): Elaborazione di un nuovo strumento per l'assessment della Qualità della Vita nella popolazione generale] 2.698
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 532
Internet Addiction Disorder in a Sample of 402 High School Students [Zespół uzależnienia od internetu w grupie 402 uczniów szkoły ̈redniej] 468
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 415
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 413
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 369
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 332
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 307
Mood stabilisers and pregnancy outcomes - a review 294
P.5.f.010 Evaluation of the treatment of elderly agitated patients:a preliminary study 290
P.1.k.034 Psychomotor agitation in emergency medicine settings 281
P.1.k.027 Autoerotic and sexual activity in psychiatric patients 280
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 272
Drug safety evaluation of aripiprazole in bipolar disorder 267
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 265
Personal resources and depression in schizophrenia: the role of self-esteem, resilience and internalized stigma 264
P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study 263
Liraglutide in psychiatric patients: preliminary results 263
Le diverse espressioni dell'ansia e della paura: per iniziare a comprendere il mondo di coloro che soffrono di disturbi d'ansia 262
Telepsychiatry: new perspectives and open issues 256
Mood disorders and bariatric surgery: a pilot study 255
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 252
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 245
Advances in treatment for postpartum major depressive disorder 244
Early warning symptoms of schizophrenia 243
P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study 236
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 235
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 233
Impulsiveness and psychiatric disorders: a transnosographic comparison among 179 psychiatric inpatients 231
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression 230
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 230
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 229
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 225
Panic agoraphobic spectrum in psychiatrically healthy subjects: impact on quality of life 223
Affective temperaments and subthreshold symptoms spectrum in a clinical sample [Temperamenti affettivi e spettri di psicopatologia sottosoglia in un campione di popolazione clinica] 223
Infertility and psychiatric morbidity 222
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 218
Quality of life, anxiety and depression in Sarcoidosis 216
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 216
Quality of life and sub threshold affective symptoms 210
Possible involvement of opioid systems in obsessive-compulsive disorder: Psychopathological considerations [Possibile coinvolgimento del sistema oppioide nel disturbo ossessivo-compulsivo e relative considerazioni psicopatologiche] 210
Confini tra disturbo ossessivo-compulsivo e depressione: Considerazioni psicopatologiche 209
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 207
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 204
Clinica della mania 203
Adult obsessive-compulsive disorder and quality of life outcomes: a systematic review and meta-analysis 203
L' impatto della psicopatologia affettiva (sia conclamata che sottosoglia) sulla qualità della vita 202
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 202
Endocrine and metabolic effects of medications used for bipolar disorder [Effetti endocrini e metabolici dei farmaci utilizzati nel disturbo bipolare] 202
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 198
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 197
Psychopharmacological treatment and personality: Cognitive schemes changes during pharmacological treatments [Psicofarmaci e personalitá: Modificazioni degli schemi cognitivi in corso di trattamenti farmacologici] 195
Benefici e potenziali rischi dell'utilizzo di antidepressivi in gravidanza: Una revisione della letteratura 195
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder 194
The asthenia issue in obsessive-compulsive disorder [II problema della astenia nel disturbo ossessivo-compulsivo] 192
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 189
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention 188
Quality of life and subthreshold obsessive-compulsive disorder 187
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 186
Accuracy of self-assessment of real-life functioning in schizophrenia 183
Spettro dell'umore e sindrome metabolica 182
The effects of undertreated chronic medical illnesses in patients with severe mental disorders 182
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 180
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 179
The long term-maximising potential for rehabilitation in patients with schizophrenia 178
Social phobia spectrum and social phobic behaviours spectrum [Lo spettro della fobia sociale e lo spettro dei comportamenti fobico-sociali] 177
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 176
Dimensional nosography of anxiety and mood disorders: The impact on quality of life [Nosografia dimensionale dei disturbi d'ansia e dell'umore: I'impatto sulla qualità di vita] 175
Social cognition in people with schizophrenia: a cluster-analytic approach 175
Per una ricerca della nuclearità maniacale al di là delle dimensioni psicopatologiche 175
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives 172
Pharmacotherapy of binge-eating disorder: a review 169
Quetiapine in post-transplant acute mania/bipolar disorder NOS 167
Transnosography of aggressiveness, a psychopathological dimension of mania [Aspetti transnosografici dell'aggressività, una delle dimensioni psicopatologiche della mania] 167
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 164
Obsessive-compulsive disorder and quality of life outcomes: Protocol for a systematic review and meta-analysis of cross-sectional case-control studies 163
null 155
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 154
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa 150
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 149
Psicopatologia della mania: dimensioni fenomenologiche 148
What can we learn from the large US Cohort study (STEP-BD) 147
Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective 144
Binge eating disorder: from clinical research to clinical practice 140
Practical guidance for prescribing trazodone extended-release in major depression 136
null 134
Human CRY1 variants associate with attention deficit/hyperactivity disorder 133
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 132
Physical activity and mental health, psychological and physiological mechanisms 131
Interazione tra farmaci 127
Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression 127
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 122
Pharmacokinetic Interactions 118
Quality of life and sensory threshold: Study in a sample of healthy subjects [Qualità della vita e fenomenica sottosoglia: Studio in un campione di soggetti sani] 116
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 115
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 110
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 110
null 106
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 103
null 100
Totale 23.241
Categoria #
all - tutte 65.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.363 83 140 123 135 97 47 88 101 129 119 71 230
2022/20233.864 98 141 247 239 172 330 62 192 2.119 117 89 58
2023/20241.934 80 55 188 100 140 501 509 64 29 62 80 126
2024/20253.188 97 201 280 259 392 230 118 132 324 140 343 672
2025/20266.306 566 813 546 647 1.270 245 715 234 268 347 190 465
2026/202761 61 0 0 0 0 0 0 0 0 0 0 0
Totale 23.537